IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated molecules

Cisplatin-based chemotherapy is currently the most effective treatment regimen for non-small cell lung cancer (NSCLC), but eventually tumor resistance develops which limits its success. The potential implication of IL-6 signaling in the cisplatin resistance of NSCLC was explored by testing whether N...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Shanzhou, Tsai, Ying, Keng, Peter, Chen, Yongbing, Lee, Soo Ok, Chen, Yuhchyau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695015/
https://www.ncbi.nlm.nih.gov/pubmed/26313152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695015/
https://www.ncbi.nlm.nih.gov/pubmed/26313152

Ejemplares similares